Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC.
暂无分享,去创建一个
[1] Peter J Tonge,et al. Translating slow-binding inhibition kinetics into cellular and in vivo effects. , 2015, Nature chemical biology.
[2] シャポー ガエル,et al. 1,2-Dihydro-3H-pyrrolo [1,2-c] imidazol-3-one derivatives and their use as antibacterial agents , 2015 .
[3] S. Andrews,et al. A Complete Pathway Model for Lipid A Biosynthesis in Escherichia coli , 2015, PloS one.
[4] 크리스띠앙 위브슈웨를랭,et al. Antibacterial 1h-indazole and 1h-indole derivatives , 2014 .
[5] Matthew D. Miller,et al. Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors. , 2014, ACS medicinal chemistry letters.
[6] M. Kuhn,et al. LpxC Inhibitors as New Antibacterial Agents and Tools for Studying Regulation of Lipid A Biosynthesis in Gram-Negative Pathogens , 2014, mBio.
[7] E. Toone,et al. Structural basis of the promiscuous inhibitor susceptibility of Escherichia coli LpxC. , 2014, ACS chemical biology.
[8] E. Toone,et al. Synthesis, structure, and antibiotic activity of aryl-substituted LpxC inhibitors. , 2013, Journal of medicinal chemistry.
[9] Matthew D. Miller,et al. Exploring the UDP pocket of LpxC through amino acid analogs. , 2013, Bioorganic & medicinal chemistry letters.
[10] Daina Zeng,et al. Mutants Resistant to LpxC Inhibitors by Rebalancing Cellular Homeostasis* , 2013, The Journal of Biological Chemistry.
[11] V. Shanmugasundaram,et al. Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agents. , 2012, Bioorganic & medicinal chemistry letters.
[12] M. Adams,et al. Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis , 2012, mBio.
[13] V. Shanmugasundaram,et al. Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections. , 2012, Journal of medicinal chemistry.
[14] V. Shanmugasundaram,et al. Potent inhibitors of LpxC for the treatment of Gram-negative infections. , 2012, Journal of medicinal chemistry.
[15] W. Dowhan. The Raetz pathway for lipid A biosynthesis: Christian Rudolf Hubert Raetz, M.D., PH.D. 1946-2011. , 2012, Glycobiology.
[16] W. Dowhan. The Raetz Pathway for Lipid A Biosynthesis: Christian Rudolf Hubert Raetz, MD PhD, 1946–2011 , 2011, Journal of Lipid Research.
[17] J. Walker,et al. Mechanisms Decreasing In Vitro Susceptibility to the LpxC Inhibitor CHIR-090 in the Gram-Negative Pathogen Pseudomonas aeruginosa , 2011, Antimicrobial Agents and Chemotherapy.
[18] R. Hill,et al. The Lipid A Assembly Pathway: The Work of Christian Raetz , 2011, The Journal of Biological Chemistry.
[19] P. Orth,et al. Design and synthesis of potent Gram-negative specific LpxC inhibitors. , 2011, Bioorganic & medicinal chemistry letters.
[20] Pei Zhou,et al. Species-specific and inhibitor-dependent conformations of LpxC: implications for antibiotic design. , 2011, Chemistry & biology.
[21] P. Zhou,et al. Syntheses, structures and antibiotic activities of LpxC inhibitors based on the diacetylene scaffold. , 2011, Bioorganic & medicinal chemistry.
[22] F. Narberhaus,et al. Control of Lipopolysaccharide Biosynthesis by FtsH-Mediated Proteolysis of LpxC Is Conserved in Enterobacteria but Not in All Gram-Negative Bacteria , 2010, Journal of bacteriology.
[23] Jian Li,et al. Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production , 2010, Antimicrobial Agents and Chemotherapy.
[24] C. Raetz,et al. Antimicrobial Activity of CHIR-090, an Inhibitor of Lipopolysaccharide Biosynthesis, against the Burkholderia cepacia Complex , 2010, Antimicrobial Agents and Chemotherapy.
[25] T. Silhavy,et al. Transport of lipopolysaccharide across the cell envelope: the long road of discovery , 2009, Nature Reviews Microbiology.
[26] C. Bertozzi,et al. Uridine-based inhibitors as new leads for antibiotics targeting Escherichia coli LpxC. , 2009, Biochemistry.
[27] I. Mochalkin,et al. Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB‐78485 inhibitor , 2008, Protein science : a publication of the Protein Society.
[28] Pei Zhou,et al. Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand binding , 2007, Proceedings of the National Academy of Sciences.
[29] Pei Zhou,et al. Inhibition of lipid A biosynthesis as the primary mechanism of CHIR-090 antibiotic activity in Escherichia coli. , 2007, Biochemistry.
[30] M. Pirrung,et al. Molecular Validation of LpxC as an Antibacterial Drug Target in Pseudomonas aeruginosa , 2006, Antimicrobial Agents and Chemotherapy.
[31] F. Narberhaus,et al. The C‐terminal end of LpxC is required for degradation by the FtsH protease , 2006, Molecular microbiology.
[32] J. Rudolph,et al. A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid A biosynthesis with antibiotic activity comparable to ciprofloxacin. , 2005, Biochemistry.
[33] N. Munshi,et al. Novel hydroxamic acid-derived HDAC inhibitor LBH589 potently activates intrinsic and extrinsic apoptotic pathways, and induces tubulin hyperacetylation in multiple myeloma. , 2005 .
[34] Brian E. Coggins,et al. Structure of the LpxC deacetylase with a bound substrate-analog inhibitor , 2003, Nature Structural Biology.
[35] C. Fierke,et al. Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] N. Andersen,et al. Potent, novel in vitro inhibitors of the Pseudomonas aeruginosa deacetylase LpxC. , 2002, Journal of medicinal chemistry.
[37] S. Chandler,et al. Antibacterial Activities and Characterization of Novel Inhibitors of LpxC , 2002, Antimicrobial Agents and Chemotherapy.
[38] J. Shimada. [Antibacterial agents]. , 2002, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.
[39] ウィッタカー,マーク,et al. Hydroxamic acid derivatives as antibacterial agents , 1999 .
[40] S. E. D. Laszlo,et al. Carbohydroxamido-oxazolidines: antibacterial agents that target lipid A biosynthesis. , 1999, Bioorganic & medicinal chemistry letters.
[41] C. Fierke,et al. Balanced biosynthesis of major membrane components through regulated degradation of the committed enzyme of lipid A biosynthesis by the AAA protease FtsH (HflB) in Escherichia coli , 1999, Molecular microbiology.
[42] A. Patchett,et al. Antibacterial Agents That Inhibit Lipid A Biosynthesis , 1996, Science.
[43] J. Lutkenhaus,et al. Regulation of UDP-3-O-[R-3-hydroxymyristoyl]-N-acetylglucosamine Deacetylase in Escherichia coli , 1996, The Journal of Biological Chemistry.
[44] C. Raetz,et al. The envA Permeability/Cell Division Gene of Escherichia coli Encodes the Second Enzyme of Lipid A Biosynthesis , 1995, The Journal of Biological Chemistry.
[45] S. Galloway,et al. UDP-N-acetylglucosamine acyltransferase of Escherichia coli. The first step of endotoxin biosynthesis is thermodynamically unfavorable. , 1993, The Journal of biological chemistry.
[46] C. Raetz,et al. Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction , 1993, Journal of bacteriology.
[47] R. Misra,et al. Identification and characterization of a new gene of Escherichia coli K-12 involved in outer membrane permeability. , 1989, Genetics.
[48] J. Lutkenhaus,et al. Sequence analysis, transcriptional organization, and insertional mutagenesis of the envA gene of Escherichia coli , 1987, Journal of bacteriology.
[49] W. Zimmermann. Penetration of beta-lactam antibiotics into their target enzymes in Pseudomonas aeruginosa: comparison of a highly sensitive mutant with its parent strain , 1980, Antimicrobial Agents and Chemotherapy.
[50] P. D. Rick,et al. Mechanism of assembly of the outer membrane of Salmonella typhimurium. Translocation and integration of an incomplete mutant lipid A into the outer membrane. , 1980, The Journal of biological chemistry.
[51] L. Leive. THE BARRIER FUNCTION OF THE GRAM‐NEGATIVE ENVELOPE , 1974, Annals of the New York Academy of Sciences.
[52] M. Osborn,et al. Mechanism of assembly of the outer membrane of Salmonella typhimurium. Site of synthesis of lipopolysaccharide. , 1972, The Journal of biological chemistry.
[53] S. Normark,et al. Mutant of Escherichia coli with Anomalous Cell Division and Ability to Decrease Episomally and Chromosomally Mediated Resistance to Ampicillin and Several Other Antibiotics , 1969, Journal of bacteriology.